Drug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinoma

Table 2 Comparison of the efficacy between Group A and Group C at the 3^rd, 6^th, and 9^th month after treatment, n (%)

	3nd month		6th month		9th month
	Group A	Group C	Group A	Group C	Group A	Group C
CR	11 (27.5)	13 (32.5)	11 (27.5)	13 (32.5)	11 (27.5)	13 (32.5)
PR	14 (35.0)	15 (37.5)	14 (35.0)	15 (37.5)	14 (35.0)	15 (37.5)
SD	13 (32.5)	11 (27.5)	12 (30.0)	10 (25.0)	10 (25.0)	10 (25.0)
PD	2 (5.0)	1 (2.5)	3 (7.5)	2 (5.0)	4 (10.0)	2 (5.0)
Efficiency	25 (62.5)	28 (70.0)	25 (62.5)	28 (70.0)	25 (62.5)	28 (70.0)
χ2 value	0.701		0.583		0.855
P value	0.873		0.900		0.836

CR: Complete remission; PR: Partial remission; PD: Progressive disease; SD: Stable disease.